http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102159436-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 |
| filingDate | 2018-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102159436-B1 |
| titleOfInvention | Composition for regulating blood coagulation comprising purified vesicles isolated from platelet for hemostasis |
| abstract | The present invention relates to a composition for controlling blood coagulation comprising a platelet-derived purified product and various uses thereof. In the platelet-derived purified product of the present invention, mitochondrial DNA (mitochondrial DNA) has been removed, and proteins other than membrane proteins have been removed, and the secretion of inflammatory cytokines is remarkably lowered to promote hemostasis. It has an agglutination effect and it has been confirmed that the bleeding time can be shortened, so it can be usefully used in the related pharmaceutical industry. |
| priorityDate | 2018-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.